You are here
Rare Disease Areas of Focus
Focus Brings Depth to Our Rare Disease Approach
With more than 20 years of experience in rare disease research, treatments approved in 81 countries, and multiple drugs in clinical trials, Pfizer is uniquely positioned to lead advances in rare disease treatment. We bring deep scientific expertise and years of exploring emerging medical frontiers to our mission with some of the world’s leading research organizations as our partners. Focusing on patient needs and our strengths will always be our strategy.